首页> 外文OA文献 >FRI0675 Rabiopred, an innovative theranostic tool to assist clinicians select an optimal anti-tnf alpha biological therapy for rheumatoid arthritis patients

【2h】

FRI0675 Rabiopred, an innovative theranostic tool to assist clinicians select an optimal anti-tnf alpha biological therapy for rheumatoid arthritis patients

机译：Fri0675 rabiopred是一种创新的Theranostic工具，用于协助临床医生为类风湿性关节炎患者选择最佳的抗TNFα生物学治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
E. Schordan; M. Coq; S. AIT ABBI NAZI; M. Mehdi; H. Firat; N. Arber; V. Breuil; L. A.-Demoux; A. Gül; E. J.-Gottenberg; G. Hatemi; T. Huizinga; N. Inanç; J. Vencovský; C. Jorgensen;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register. [J] . Galloway JB, Hyrich KL, Mercer LK, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2011,第10期

机译：类风湿关节炎患者感染性关节炎的风险和抗TNF治疗的效果：英国风湿病生物学学会注册的结果。
2. Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial [J] . Peter C. Taylor, Didier Saurigny, Jiri Vencovsky, Arthritis research & therapy. . 2019,第1期

机译：抗风湿性关节炎（RA）患者对甲氨蝶呤背景疗法的反应不足，对抗氨甲蝶呤疗法的反应不足或不耐受的类风湿性关节炎（RA）患者抗粒细胞巨噬细胞集落刺激因子（GM-CSF）配体的人类单克隆抗体那米单抗的疗效和安全性-TNF（肿瘤坏死因子）生物疗法：一项随机对照试验
3. Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis: does early anti-TNF therapy bring patients back to work? [J] . Olofsson T., Petersson I. F., Eriksson J. K., Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2017,第7期

机译：在瑞典类风湿性关节炎的国家队列患者中抗TNF治疗开始后的工作障碍预测因素：早期抗TNF治疗使患者恢复工作吗？
4. Patient-Clinician Co-Design Co-Participation in Design of an App for Rheumatoid Arthritis Management via Telehealth Yields an App with High Usability and Acceptance [C] . Rebecca Grainger, Hermaleigh Townsley, Tobias Langlotz, MEDINFO . 2017

机译：患者 - 临床医生协同设计通过远程医疗的类风湿性关节炎管理设计的应用程序的设计产生了一个高可用性和接受的应用程序
5. “Don’t Rock the Boat”: A Qualitative Narrative Study Exploring Rheumatoid Arthritis Patients’ Experience of Illness and Biologics [D] . Rachich, Meagan . 2020

机译：“不要摇滚船”：探索类风湿性关节炎患者的疾病和生物学经验的定性叙事研究
6. Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort [O] . J Bluett, I Ibrahim, D Plant, -1

机译：英国风湿性关节炎队列中开始抗TNF治疗的患者中补体受体1基因变异与基线红细胞沉降率的关联：类风湿关节炎遗传学和基因组学研究辛迪加队列研究结果
7. Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. [O] . Bluett, J, Ibrahim, I, Plant, D, 2014

机译：英国风湿性关节炎队列中开始抗TNF治疗的患者中补体受体1基因变异与基线红细胞沉降率水平的关联：类风湿关节炎遗传学和基因组学研究辛迪加队列中的生物学研究结果。

FRI0675 Rabiopred, an innovative theranostic tool to assist clinicians select an optimal anti-tnf alpha biological therapy for rheumatoid arthritis patients

著录项

引文网络

相似文献

相关主题

期刊订阅